1Rugge M, Correa P, Dixon M F, et al. Gastric mucosal atrophy : interob- server consistency using new criteria for classification and grading[ J ]. Aliment Pharmacol Ther,2002,16 ( 7 ) : 1249.
2Whiting J L, Sigurdsson A, Rowlands D C, et al. The long term results of endoscopic surveillance of premalignant gastric lesions [ J ]. Gut, 2002, 50(3) :378.
3Uemura N,Okamoto S,Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer[ J]. N Engl J Med, 2001,345 (11):784.
4Yokota S ,Amano K,Fujii N,et al. Comparision of serum antibody titers to Helicobacter pylori lipopolysaccharides, CagA, VaeA and partially pu- rified cellular extracts in a Japanese population [ J ]. FEMS Microbiol lett ,2000,185 ( 2 ) : 193.
4SUNGJ J,LIN S R, CHING J Y L, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection:aprospective, randomized study [J]. Gastroenterology, 2000,119(1) :7-14.
5CORREA P, FONTHAM E T H, BRAVE J C, et al.Chemoprevention of gastric dysplasia: randomized controlled trial of antiosidant supplements and anti-Helicobacter therapy [J]. J Natl Cancer Inst,2000,92(23): 1881-1888.
6HULST K W A,ENDE A,DEKKER F W, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA:a prospective 1 year follow-up study [J]. Gastroenterology,1997,113(1) :25-30.
7GENTA R M, GRAHAM D Y. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori[J]. Scand J gastroenterol, 1993,28 (10) :924-928.
8TYTGAT T N J. Remaining questions with respect to Helicobacter pylori [ J ]. Gastrointestinal Endoscopy, 1998, 47(2) :198-199.
9SHIRIN A H,SORDILLO E M, OH S H, et al. Helicobacter pylori inhibits the G (1) to S transition in AGS gastric epithelial cells[J]. Cancer Res,1999, 59(10) :2277-2281.
